This is therefore a very heterogeneous AML group with regard to differentiation/phenotype; whereas, in contrast, the large majority of T-ALL with SET-NUP214 fusion share a common characteristic—TCRγδ expression [133]. The gene discussed is NUP214; the disease is acute lymphoblastic leukemia.